LYEL Competitors & Alternatives
Compare Lyell Immunopharma Inc with similar stocks in the same industry
Biotechnology
LYEL
Main Stock$12.57
Tradestie Score
42
Market Cap
$317.95M
Revenue Growth
-0.7%
Analyst Upside
+235.7%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.44
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.88
|
$382.04M | - | 50 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.58
|
$371.64M | - | 58 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$27.64
|
$357.51M | - | 52 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.21
|
$354.45M | - | 54 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$27.95
|
$353.70M | - | 60 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.73
|
$350.98M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.87
|
$341.56M | - | 61 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.39
|
$332.96M | - | 58 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.98
|
$328.62M | - | 58 | Compare |
More LYEL Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry